OnCo
drugsProductNot mapped hereapproved

Vincristine

A plant-derived chemotherapy from the Madagascar periwinkle that has been in almost every childhood leukaemia and lymphoma regimen since the 1960s.

Approved 1963. Component of CHOP, ABVD-era regimens, ALL induction/maintenance, VAC/VDC (rhabdomyosarcoma, Ewing), Wilms tumour (VA/DD-4A), neuroblastoma and medulloblastoma regimens, EMA-CO. Fatal if given intrathecally; vincristine shortages (2019) disrupted paediatric care. Liposomal vincristine (Marqibo, 2012) for Ph-negative ALL was discontinued 2022.

Loading structure…
|
Vincristine · 2D coordinates (no PubChem conformer)
PubChem
Modality
Vinca alkaloid (microtubule inhibitor)
Mechanism
Binds β-tubulin and prevents microtubule polymerisation, arresting mitosis; dose-limited by peripheral neuropathy.
Brand / code
Oncovin / Marqibo
Medicare
Part B (clinician-administered)

Given by infusion or injection in a clinic or hospital outpatient department, so it is a Part B drug: Medicare pays 80% after the Part B deductible and the patient owes 20% coinsurance, uncapped in Original Medicare unless a Medigap policy applies. Generic; Marqibo (liposomal) was discontinued.

Commercial insurance
covered on label

Multi-source generic; covered under the medical benefit without prior authorisation in most plans, as part of standard regimens.

Sources: Medicare.gov: Chemotherapy · Medicare.gov: Prescription drugs (outpatient, Part B). Not medical or financial advice; verify with your plan.

Not appraisedSearch NICE
Notes
Long-established generic: never subject to a technology appraisal; funded routinely through hospital formularies and NHS England systemic anti-cancer therapy protocols.
NHS England
Routinely funded for the appraised indication (or via managed access)

Sources: NICE search: vincristine. Funding decisions are indication-specific and change monthly; verify with NICE and your treating team.

Regulatory

1top

Approvals

RegionYearIndication
US1963Acute leukaemia; Hodgkin and non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, Wilms tumour

Trials

top
ClinicalTrials.gov · phase 2/3
refreshed 2026-09-09
1105 studies14 recruiting65 Phase 237 Phase 3
Search “Vincristine” on ClinicalTrials.gov →
Counts are from a name search and may include unrelated studies; up to 100 studies are summarised.

Recruiting now (live from ClinicalTrials.gov)

Recruiting trials near you · live from ClinicalTrials.gov
Vincristine
intervention: Vincristine
Open on ClinicalTrials.gov →

Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.

Key papers

1top

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this drug: (TITLE:"Vincristine" OR ABSTRACT:"Vincristine" OR TITLE:"Oncovin" OR ABSTRACT:"Oncovin" OR TITLE:"Marqibo" OR ABSTRACT:"Marqibo") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Vincristine, not a curated reading list.

Connected

20top

Pages like this

not linked directly; found by shared links